A purple and pink letter v on a white background.
September 29, 2021

Medical Tourism After COVID-19

 

 As the risks of the pandemic begin to alleviate,  medical tourism  is poised to bounce back after a prolonged hiatus. Soon, people will start to travel for the purpose of getting the best medical aesthetic treatments from the best providers. While this uptick is a boon to the global aesthetics market, it could come as unwelcome news to the domestic market as clinics struggle to revive their business to pre-pandemic numbers. However, it is possible for every clinic to capitalize on the medical tourism trend by becoming familiar with what patients are willing to travel for, and by offering the aesthetic treatments that meet their needs.   

 

Popular Destinations  For  Medical Tourism  

Over time, some locations have become known for certain cosmetic surgeries or aesthetic treatments. This usually happens when a particular clinic performs the procedure successfully, and patients flock there to obtain it, after which more clinics offer the same treatment to take advantage of the trend. If the trend is big enough, it has the effect of eventually attracting more specialists to that locale, making it a trusted destination for that procedure. Popular destinations include:  

  • South Korea for plastic surgeries  such as  nose jobs and double-eyelid surgery    
  • Turkey for  inexpensive  hair restoration  where  clinics compete against each other to get the lowest prices possible
  • Hollywood for injectables  such as Botox and lip fillers  
  • Miami for  B razilian Butt Lifts  and breast implants   
  • Thailand and Brazil for body surgeries    

Medical Tourism  And  Your Patients  

One thing your clinic can do to prevent losing part of your customer base to these far-flung destinations is to open a discussion with them about medical tourism. Despite the attraction of getting a treatment in an exotic locale, there are several inherent drawbacks of traveling for an aesthetic procedure. Different countries have different, and sometimes looser, regulatory stipulations for who can perform a medical aesthetic procedure and how it can be performed. Another important safety concern is the stress that travel puts on the body, which should be a top concern for any procedure that requires recovery time, when stress should be avoided at all costs. Speaking of cost, traveling for a treatment tends to be quite expensive. Even if the destination boasts cheap clinic prices, the costs of traveling and accommodation usually negate these savings. Furthermore, a clinic that has a revolving door of foreign patients isn t going to offer the same post-procedure support that a local provider will be able to. When it comes to medical aesthetics, that personal touch of customized care from a practitioner who knows you can t be underestimated.    

How To Make Your Clinic  A  Medical Tourism Destination  

During lockdown, people everywhere learned to appreciate the benefits of shopping local, and those benefits extended to the aesthetics market. The truth is, the superiority of the procedures offered in these medical tourism hotspots is overblown since the advanced technology that makes them possible is available globally. In fact, many of these state-of-the-art devices are manufactured by domestic innovators like Venus Concept. Our devices are in use in clinics all over the world, making them available to clinics anywhere. You can encourage patients who are itching to travel for treatment to stay local instead by offering the most sought-after treatments delivered by the most trusted technology.   

Popular treatments to compete with those offered abroad include n on- i nvasive  l ipolysis , delivered via  our   Venus Bliss  and  Venus Versa  machines, and hair restoration with  NeoGraft®  and  ARTAS® .  Ma ny of our partner clinicians, such as Dr. Michael  Wolfeld  in Manhattan, have made a name for themselves by specializing in one procedure.  Dr. Wolfeld is the top hair restoration surgeon in Manhattan , and his patients travel from far and wide seeking his service. However, to maximize your clinic s appeal it s a good practice to offer a range of i nvasive  and  non-invasive treatments for  patients  to  choose from.  

Another way you can draw more interest to your clinic is by tweaking your  marketing strategy   so  it attracts a local clientele. There are multiple ways to do this, like using local business listings, localized SEO, and digital advertising, or by tapping local influencers to boost your reach on social media. The best advertising, of course, is the kind that s free. Word of mouth is your best tool when it comes to bringing new patients through your doors, and it s as easy as keeping your current patients happy and satisfied.    

Looking Ahead  For  Your Clinic  

While medical tourism is sure to bounce back post-COVID as well as the rest of the aesthetics industry, experts expect that  it could take three or more years to do so . This is more than enough time for your clinic to renew its service offerings and present a strong appeal for patients looking to return to their aesthetics plan. Speak to one of our experts today about our state-of-the-art medical devices and business support services.  

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.